Sonexa Therapeutics Inc., a San Diego-based drug startup focused on the treatment of Alzheimer's disease, has raised $30 million in Series A funding. Domain Associates, Scale Venture Partners and Alta Partners co-led the round, and were joined by AgeChem Venture Fund and MC Life Science Ventures.